Hedge fund Two Seas Capital says tie-up’s structure is ‘deficient’ and could undervalue the target
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
One of Core Scientific’s biggest investors has threatened to launch a proxy battle against CoreWeave’s planned purchase of the group, arguing that the deal’s str... [2473 chars]